Journal of Diagnostics Concepts & Practice ›› 2021, Vol. 20 ›› Issue (01): 104-108.doi: 10.16150/j.1671-2870.2021.01.017
• Review article • Previous Articles Next Articles
Received:2020-11-04
Online:2021-02-25
Published:2022-06-28
CLC Number:
| [1] |
Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia[J]. J Hepatol, 2017, 67(4):862-873.
doi: 10.1016/j.jhep.2017.06.003 URL |
| [2] |
Trouwborst I, Verreijen A, Memelink R, et al. Exercise and nutrition strategies to counteract sarcopenic obesity[J]. Nutrients, 2018, 10(5):605.
doi: 10.3390/nu10050605 URL |
| [3] |
Dulloo AG, Jacquet J, Solinas G, et al. Body composition phenotypes in pathways to obesity and the metabolic syndrome[J]. Int J Obes (Lond), 2010, 34(Suppl 2):S4-S17.
doi: 10.1038/ijo.2010.234 URL |
| [4] |
Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences[J]. Int J Mol Sci, 2020, 21(2):494.
doi: 10.3390/ijms21020494 URL |
| [5] |
Al-Sofiani ME, Ganji SS, Kalyani RR. Body composition changes in diabetes and aging[J]. J Diabetes Complications, 2019, 33(6):451-459.
doi: 10.1016/j.jdiacomp.2019.03.007 URL |
| [6] |
Albano D, Messina C, Vitale J, et al. Imaging of sarcopenia: old evidence and new insights[J]. Eur Radiol, 2020, 30(4):2199-2208.
doi: 10.1007/s00330-019-06573-2 URL |
| [7] |
Koster A, Visser M, Simonsick EM, et al. Association between fitness and changes in body composition and muscle strength[J]. J Am Geriatr Soc, 2010, 58(2):219-226.
doi: 10.1111/j.1532-5415.2009.02681.x URL |
| [8] |
Siervogel RM, Wisemandle W, Maynard LM, et al. Serial changes in body composition throughout adulthood and their relationships to changes in lipid and lipoprotein levels. The Fels Longitudinal Study[J]. Arterioscler Thromb Vasc Biol, 1998, 18(11):1759-1764.
doi: 10.1161/01.ATV.18.11.1759 URL |
| [9] |
Hughes VA, Frontera WR, Roubenoff R, et al. Longitudinal changes in body composition in older men and wo-men: role of body weight change and physical activity[J]. Am J Clin Nutr, 2002, 76(2):473-481.
doi: 10.1093/ajcn/76.2.473 URL |
| [10] |
Wang Z, Xu M, Peng J, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly[J]. Exp Gerontol, 2013, 48(8):705-709.
doi: 10.1016/j.exger.2013.05.059 URL |
| [11] |
Wijarnpreecha K, Panjawatanan P, Aby E, et al. Nonalcoholic fatty liver disease in the over-60s: impact of sarcopenia and obesity[J]. Maturitas, 2019, 124:48-54.
doi: S0378-5122(19)30106-9 pmid: 31097179 |
| [12] |
Cha JY, Kim DH, Chun KH. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Lab Anim Res, 2018, 34(4):133-139.
doi: 10.5625/lar.2018.34.4.133 URL |
| [13] |
Pownall HJ, Schwartz AV, Bray GA, et al. Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD study[J]. Obesity (Silver Spring), 2016, 24(9):1899-1905.
doi: 10.1002/oby.21577 URL |
| [14] |
Hita-Contreras F, Bueno-Notivol J, Martínez-Amat A, et al. Effect of exercise alone or combined with dietary supplements on anthropometric and physical performance measures in community-dwelling elderly people with sarcopenic obesity: a meta-analysis of randomized controlled trials[J]. Maturitas, 2018, 116:24-35.
doi: S0378-5122(18)30416-X pmid: 30244776 |
| [15] |
Villareal DT, Chode S, Parimi N, et al. Weight loss, exer-cise, or both and physical function in obese older adults[J]. N Engl J Med, 2011, 364(13):1218-1229.
doi: 10.1056/NEJMoa1008234 URL |
| [16] |
Hannah WN Jr, Harrison SA. Effect of weight loss, diet, exercise, and bariatric surgery on nonalcoholic fatty liver disease[J]. Clin Liver Dis, 2016, 20(2):339-350.
doi: 10.1016/j.cld.2015.10.008 URL |
| [17] |
Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, et al. Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: a randomized controlled trial[J]. J Clin Oncol, 2018, 36(9):875-883.
doi: 10.1200/JCO.2017.75.7526 pmid: 29356607 |
| [18] |
Buchwald H, Buchwald JN. Metabolic (bariatric and nonbariatric) surgery for type 2 diabetes: a personal perspective review[J]. Diabetes Care, 2019, 42(2):331-340.
doi: 10.2337/dc17-2654 pmid: 30665965 |
| [19] |
Tamboli RA, Hossain HA, Marks PA, et al. Body composition and energy metabolism following Roux-en-Y gastric bypass surgery[J]. Obesity (Silver Spring), 2010, 18(9):1718-1724.
doi: 10.1038/oby.2010.89 URL |
| [20] |
Pontiroli AE, Folli F, Paganelli M, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study[J]. Diabetes Care, 2005, 28(11):2703-2709.
pmid: 16249543 |
| [21] |
Metcalf B, Rabkin RA, Rabkin JM, et al. Weight loss composition: the effects of exercise following obesity surgery as measured by bioelectrical impedance analysis[J]. Obes Surg, 2005, 15(2):183-186.
doi: 10.1381/0960892053268381 URL |
| [22] |
Alba DL, Wu L, Cawthon PM, et al. Changes in lean mass, absolute and relative muscle strength, and physical performance after gastric bypass surgery[J]. J Clin Endocrinol Metab, 2019, 104(3):711-720.
doi: 10.1210/jc.2018-00952 URL |
| [23] |
Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients[J]. Gastroenterology, 2015, 149(2):379-388,e15-e16.
doi: 10.1053/j.gastro.2015.04.014 URL |
| [24] |
Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2019, 17(6):1040-1060.
doi: 10.1016/j.cgh.2018.10.017 URL |
| [25] |
Immonen H, Hannukainen JC, Kudomi N, et al. Increased liver fatty acid uptake is partly reversed and liver fat content normalized after bariatric surgery[J]. Diabetes Care, 2018, 41(2):368-371.
doi: 10.2337/dc17-0738 pmid: 29158250 |
| [26] |
Froylich D, Corcelles R, Daigle C, et al. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study[J]. Surg Obes Relat Dis, 2016, 12(1):127-131.
doi: 10.1016/j.soard.2015.04.004 pmid: 26077701 |
| [27] |
Poggiogalle E, Donini LM, Lenzi A, et al. Non-alcoholic fatty liver disease connections with fat-free tissues: a focus on bone and skeletal muscle[J]. World J Gastroenterol, 2017, 23(10):1747-1757.
doi: 10.3748/wjg.v23.i10.1747 URL |
| [28] |
Kim JA, Choi KM. Sarcopenia and fatty liver disease[J]. Hepatol Int, 2019, 13(6):674-687.
doi: 10.1007/s12072-019-09996-7 URL |
| [29] |
Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mecha-nism of the pathogenesis[J]. Ageing Res Rev, 2017, 35:200-221.
doi: S1568-1637(16)30130-1 pmid: 27702700 |
| [30] |
Pacifico L, Perla FM, Chiesa C. Sarcopenia and nonalcoholic fatty liver disease: a causal relationship[J]. Hepatobiliary Surg Nutr, 2019, 8(2):144-147.
doi: 10.21037/hbsn.2018.11.11 URL |
| [31] |
Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities[J]. J Endocrinol, 2016, 229(2):R67-R81.
doi: 10.1530/JOE-15-0533 URL |
| [32] |
Riddle RC, Clemens TL. Insulin, osteoblasts, and energy metabolism: why bone counts calories[J]. J Clin Invest, 2014 Apr; 124(4):1465-1467.
doi: 10.1172/JCI75554 pmid: 24642463 |
| [33] |
Karampela I, Christodoulatos GS, Dalamaga M. The role of adipose tissue and adipokines in sepsis: inflammatory and metabolic considerations, and the obesity paradox[J]. Curr Obes Rep, 2019, 8(4):434-457.
doi: 10.1007/s13679-019-00360-2 pmid: 31637623 |
| [34] |
Scott IC, Tomlinson W, Walding A, et al. Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis[J]. J Cachexia Sarcopenia Muscle, 2013, 4(2):157-169.
doi: 10.1007/s13539-012-0097-z pmid: 23344890 |
| [35] |
Budick-Harmelin N, Dudas J, Demuth J, et al. Triglyce-rides potentiate the inflammatory response in rat Kupffer cells[J]. Antioxid Redox Signal, 2008, 10(12):2009-2022.
doi: 10.1089/ars.2007.1876 URL |
| [36] |
Jiang W, Wu N, Wang X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease[J]. Sci Rep, 2015, 5:8096.
doi: 10.1038/srep08096 URL |
| [37] |
Poggiogalle E, Lubrano C, Gnessi L, et al. Fatty liver index associates with relative sarcopenia and GH/IGF-1 status in obese subjects[J]. PLoS One, 2016, 11(1):e0145811.
doi: 10.1371/journal.pone.0145811 URL |
| [38] |
Cabrera D, Ruiz A, Cabello-Verrugio C, et al. Diet-induced nonalcoholic fatty liver disease is associated with sarcopenia and decreased serum insulin-like growth factor-1[J]. Dig Dis Sci, 2016, 61(11):3190-3198.
doi: 10.1007/s10620-016-4285-0 URL |
| [39] |
Cabrera D, Cabello-Verrugio C, Solís N, et al. Somatotropic axis dysfunction in non-alcoholic fatty liver di-sease: beneficial hepatic and systemic effects of hormone supplementation[J]. Int J Mol Sci, 2018, 19(5):1339.
doi: 10.3390/ijms19051339 URL |
| [1] | PAN Xiaoxi, CAO Jiumei, WU Fang. Correlation between brown adipogenic capacity of preadipocytes and ageing and the related mechanism in mice [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 272-277. |
| [2] | ZHANG Miao, ZHANG Ying, SHI Lixin, ZHANG Qiao, PENG Nianchun, HU Ying. Awareness, treatment and control of dyslipidemia in middle-aged and older population in Guiyang: A three-year follow-up study [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(05): 487-491. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
